Relationship between peripheral and mesenteric serum levels of CEA and CA 242 with staging and histopathological variables in colorectal adenocarcinoma

Acta Cirurgica Brasileira

Volumn 24, Issue 5, 2009, Pages 405-410

  Cardoso, Mauro Lamelas ^a   Fernandes, Luís Cesar ^a   Su, Bong Kim ^a   Matos, Delcio ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hospital of the School of Medicine   (Brazil)

Author keywords

Adenocarcinoma; Colon; Prognosis; Rectum; Tumor Markers, Biological

Indexed keywords

CA 242 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CELL DIFFERENTIATION; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MESENTERY; MORPHOLOGY; PERIPHERAL CIRCULATION; PROTEIN BLOOD LEVEL; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MESENTERIC ARTERIES; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 70350739135     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502009000500012     Document Type: Article

References (17)

1. Brasil. Ministério da Saúde. Coordenação de Prevenção e Vigilância de Câncer. Estimativas 2008: Incidência de Câncer no Brasil. Rio de Janeiro: INCA; 2007.
2. Meguerditchian AN, Bairati I, Lagace R, Harel F, Kibrite A. Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma. Am J Surg. 2005;189(6):707-713 (Pubitemid 40725742)
3. Bates SE. Clinical applications of serum tumor markers. Ann Intern Med. 199115;115(8):623-638
4. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965;122(3):467-481
5. Thomas P, Zamcheck N. Role of the liver in clearance and excretion of circulating carcinoembryonic antigen (CEA). Dig Dis Sci. 1983;28(3):216-224 (Pubitemid 13158755)
6. Carpelan-Holmstrom M, Louhimo J, Stenman UH, Alfthan H, Jarvinen H, Haglund C. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer. Tumour Biol. 2004;25(5-6):228-234 (Pubitemid 40082324)
7. Carpelan-Holmstrom M, Haglund C, Lundin J, Jarvinen H, Roberts P. Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer. Eur J Cancer. 1996;32A(7):1156-1161 (Pubitemid 26231796)
8. Kim SB, Fernandes LC, Saad SS, Matos D. Assessment of the value of preoperative serum levels of CA 242 and CEA in the staging and postoperative survival of colorectal adenocarcinoma patients. Int J Biol Markers. 2003;18(3):182-187 (Pubitemid 37254283)
9. Tabuchi Y, Deguchi H, Imanishi K, Saitoh Y. Colorectal cancer patients with high risk of hematogenous metastasis: correlation with CEA levels in peripheral and draining venous blood during the period of operation. J Surg Oncol. 1991;47(2):87-91.
10. Tabuchi Y, Deguchi H, Imanishi K, Saitoh Y. Comparison of carcinoembryonic antigen levels between portal and peripheral blood in patients with colorectal cancer. Correlation with histopathologic variables. Cancer. 1987;59(7):1283-1288
11. Waisberg J, Contim-Neto L, Oliveira MS, Matheus CO, Nagashima CA, Goffi FS. Determination of carcinoembryonic antigen levels in peripheral and draining venous blood in patients with colorectal carcinoma. Arq Gastroenterol. 2004;41(2):88-92. (Pubitemid 39422975)
12. Knudsen JB, Nilsson T, Sprechler M, Johansen A, Christensen N. Venous and nerve invasion as prognostic factors in postoperative survival of patients with resectable cancer of the rectum. Dis Colon Rectum. 1983;26(9):613-617
13. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124(7):979-994
14. Forones NM, Tanaka M, Falcao JB. CEA as a prognostic index in colorectal cancer. Sao Paulo Med J. 1997;115(6):1589-1592
15. Forones NM, Tanaka M, Machado D, Falcao JB, Giovanoni M. Carcinoembryonic antigen in diagnosis and monitoring of colorectal cancer. Arq Gastroenterol. 1997;34(1):3-6. (Pubitemid 127453819)
16. Fernandes LC, Kim SB, Matos D. Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma. World J Gastroenterol. 2005;11(5):645-648 (Pubitemid 40227373)
17. Fernandes LC, Kim SB, Saad SS, Matos D. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer. World J Gastroenterol. 2006;12(24):3891-3894 (Pubitemid 44028404)